Pediatricians near Tuckahoe, NY

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: My interest in pediatric pulmonology started early in my training, when I had the opportunity to work in an asthma clinic for children. I chose to specialize in lung diseases affecting children because this population is very special; they are both inherently vulnerable but also remarkably resilient. I love developing relationships with my patients and their families and consider it a privilege to take part in their care. Children are referred to me for a variety of reasons, such as difficulty breathing, frequent cough, difficulty exercising, snoring, swallowing problems, weakness, prematurity, and frequent lung infections. Left untreated, many of the underlying conditions causing these symptoms can have severe long term effects. It is essential that growing children are able to sleep well, breathe comfortably, be physically active, and receive adequate nutrition safely. I work with families, my colleagues, and physicians in other medical specialties to ensure that my patients reach these goals. My research interests have been primarily related to basic mechanisms driving inflammation in patients with asthma. In our laboratory, I work with other pulmonologists and scientists to study the roles of various proteins produced by our body and how they can worsen or mitigate asthma. More recently, I have started to study how these proteins affect lung development in babies. Another one of my interests is medical education, and I am involved in an innovative project designing instructional tools to teach doctors in training more about pediatric pulmonology.

Biography: Dr. Fangming Lin joined CUMC in June 2011 as the Division Director of Pediatric Nephrology after 10 years of serving University of Texas Southwestern Medical Center at Dallas. She received her MD degree from Fujian Medical University in China and her PhD degree in Pharmacology at New York Medical College. Dr. Lin underwent pediatric residency training at New York University Medical Center and pediatric nephrology fellowship training at Seattle Children's Hospital of the University of Washington. As a physician scientist, Dr. Lin has a strong interest in both patient care and science and discovery. She is passionate and experienced in treating children with congenital kidney conditions as well as acquired kidney diseases. Her laboratory research focuses on the understanding and better treatment for acute and chronic kidney disease. She is the first recipient of the Norman Siegel Pediatric Research Grant Award jointly issued by the American Society of Nephrology (ASN) and the American Society of Pediatric Nephrology (ASPN) in 2006 - a humbling selection of which she is proud. Dr. Lin has also served on several committees at the national and international levels. Email: fl2300@cumc.columbia.edu

Biography: Joshua Milner is a leader in the field of discovery and immunopathogenesis of genetic diseases that lead to allergic symptoms. Among the disorders he has described and/or found major mechanistic insight are PLAIDan immune disorder that leads to lifelong cold urticaria, the glycosylation disorder PGM3 deficiency, ERBIN mutation, CARD11 dominant negative mutations, STAT3 gain-of-function, Hereditary Alpha Tryptasemia Syndrome, IL-6 receptor deficiency, and others. Dr. Milner graduated with an SB in biology from the Massachusetts Institute of Technology (MIT) in 1995 and an MD with distinction in immunology from the Albert Einstein College of Medicine. He completed his residency in pediatrics at the Children's National Medical Center in Washington, DC, and, as the recipient of the Pediatric Scientist Development Program Fellowship, did his fellowship in allergy and immunology at NIAID. He completed a postdoctoral fellowship with Dr. William E. Paul, NIAID, examining issues of mouse T-cell receptor repertoires before beginning as an investigator in the Laboratory of Allergic Diseases in the NIAID, where he was eventually named chief. Dr. Milner's vision is to establish how genetic variation can help inform diagnosis and care of all patients with allergic diseaserare and common, severe and mild. This is achieved by performing genetic sequencing on samples from patients with allergic disease of all sorts, as well as performing functional studies on the same patient samples, which together help point to specific immune pathways that may be fundamentally causing disease. This comprehensive analysis, when performed in larger populations, will help personalize medicine so that patients can be better categorized for targeted care. Furthermore, this type of research and care requires a coordinated and comprehensive interdisciplinary approach, taking advantage of the expertise across the department of pediatrics and at multiple outpatient sites.

Biography: Dr. DiLorenzo is a board-certified pediatric cardiologist and Assistant Professor of Pediatrics at Columbia University Irving Medical Center. He specializes in non-invasive imaging within the division of Pediatric Cardiology. He received a Bachelor of Arts from Columbia University and his medical degree from New York University (NYU) School of Medicine. He completed his residency training at the Children's Hospital at Montefiore in the Bronx, NY prior to completing his pediatric cardiology fellowship and subspecialty training in non-invasive imaging at the Children's Hospital of Philadelphia. During that time, he received a T32 research training grant and earned a Master of Science in Clinical Epidemiology (MSCE) at Perelman School of Medicine at the University of Pennsylvania. Dr. DiLorenzo specializes in non-invasive imaging, including cardiac magnetic resonance imaging and transthoracic and transesophageal echocardiography. He is also co-director of the Pediatric Comprehensive Marfan Clinic. His research interests include non-invasive markers of right ventricular structure and function in patients with congenital heart disease.

Biography: Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children's Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation. Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Priyanka Asrani, MD is a Pediatrics Specialist who practices in New York, NY. She has been practicing for 14 years. Dr. Priyanka Asrani, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dani Dumitriu, MD, PhD, is trained as a general pediatrician, neuroscientist, and pediatric environmental health scientist. She joined Columbia University as an Associate Professor of Pediatrics (in Psychiatry) in November 2018. She dedicates 80% of her time to basic science research into the neurobiological basis of resilience as the Principal Investigator of the DOOR lab (Developmental Origins of Resilience lab) at the New York State Psychiatric Institute and 20% time to caring for newborns in the Well-Baby Nursery at the Morgan Stanley Children's Hospital of New York. The overarching goal of Dr. Dumitriu's research program is to understand and harness the neurocircuits of resilience to spearhead novel approaches to primary prevention. This is motivated by the observation that during the last century, medicine has made unprecedented progress in the treatment of disease, with a lack of parallel advancement in the prevention of disease. Consequently, the largest current worldwide disease burden comes from preventable mental and physical illnesses, such as depression, anxiety, diabetes, and hypertension. Stressful life events, particularly during critical developmental periods, have been linked to increased risk of virtually all diseases, including metabolic and cardiovascular ones, and a significant effort is underway to understand stress-induced biological consequences. However, even in the presence of the most severe stressors, some individuals remain resistant to the development of stress-induced pathology. Identifying the neurobiological basis for this natural resilience can therefore lead to the development of novel preventative strategies aimed at strengthening resiliency circuits. To tackle the mechanisms for individual variability in stress-responses, the DOOR lab uses several animal models, with the overarching unifying goal of understanding the structure, function, and Developmental Origins of Resilience. In a mouse model of adult social defeat stress, we dissect preexisting neurocircuit structure-function differences in susceptible versus resilient animals using state-of-the-art tools including in vivo chemogenetics, optogenetics, and miniscope imaging, ex vivo super-resolution imaging of dendritic spines, ex vivo whole-brain imaging of functional or structural connectivity using a variety of genetic and/or viral labeling tools, and graph theoretical analysis of co-activation patterns as a proxy for functional connectomics. In a separate set of experiments, we combine rat early-life maternal separation with wireless EEG and/or EKG recordings in dams and their pups. This data is used to understand individual variability in developmental trajectories and the role of dam-pup autonomic synchrony as a potential protective factor. Parallel EKG recordings and synchrony analyses are being conducted during mother-infant interactions in the newborn nursery. Finally, the lab is spearheading a study on wild rat stress-responses, asking the simple question: do depressive-like states occur in the wild, or are they a genetic and environmental epiphenomenon of laboratory breeding? In addition to answering questions about the neurobiological basis for resilience, the DOOR lab is committed to the development of new tools and to the movement toward #openscience. In collaborative work with two different engineering groups, we are developing novel wireless telemetry devices for wild rats and a robotic solution for ex vivo neuronal microinjections. Recently, we also launched a website, MouseCircuits.org, as an open science repository of chemogenetic and optogenetic circuit dissection. LinksMouseCircuits.orgwww.ps.columbia.edu/COMBO